Clinical Trial Update: Human Heterologous Liver Cells for Infusion in Children With Urea Cycle Disorders [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating allogeneic hepatocyte infusions for children with urea cycle disorders was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urea Cycle Disorders

Drugs mentioned

• Allogeneic hepatocyte infusion product (Allogeneic human hepatocytes for infusion)

Snippet

Sponsor: Cytonet GmbH & Co. KG | Conditions: Urea Cycle Disorders | Phase 2 | Status: TERMINATED